Hai Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
-
- Immune Cell Function and Interaction
Papers in
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 6
-
- Thyroid Cancer Diagnosis and Treatment 5
- Diabetes Management and Research 4
- Diabetes Treatment and Management 4
Hai Li
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 414
- Immunology 202
- Endocrinology, Diabetes and Metabolism 157
- Oncology 223
- Molecular Biology 532
Countries citing papers authored by Hai Li
This map shows the geographic impact of Hai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Li more than expected).
Fields of papers citing papers by Hai Li
This network shows the impact of papers produced by Hai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Li. The network helps show where Hai Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 5 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 14 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 5 | |
| 13 | 2019 | 11 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 11 | |
| 16 | 2019 | 1 | |
| 17 | 2019 | 16 | |
| 18 | 2018 | 5 | |
| 19 | 2017 | 13 | |
| 20 | Analysis of the Effect of Biomeasures on Discarded Salkaline Land in Chidamu Basin | 2002 | 2 |
About Hai Li
Hai Li is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Rehabilitation, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 66 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (6 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Diabetes Management and Research (4 papers), Diabetes Treatment and Management (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (414 citations), Immunology (202 citations), Endocrinology, Diabetes and Metabolism (157 citations), Oncology (223 citations) and Molecular Biology (532 citations). Hai Li has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Feng Li, Chunlei Wang, Zhenwei Qiu, Yanbing Li, Haipeng Xiao, Weiwei Liang, Guohong Wei, Hongyu Guan, Hongyu Guan and Liehua Liu. Their work appears in journals such as Endocrine Connections, Cell & Bioscience, BMC Primary Care, The Journal of Clinical Endocrinology & Metabolism and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.